Published in BMC Cancer on October 25, 2011
Cancer across the tree of life: cooperation and cheating in multicellularity. Philos Trans R Soc Lond B Biol Sci (2015) 1.00
Disease-on-a-chip: mimicry of tumor growth in mammary ducts. Lab Chip (2013) 0.83
An immunofluorescent method for characterization of Barrett's esophagus cells. J Vis Exp (2014) 0.75
Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33
Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A (2010) 4.47
Drosophila myc regulates organ size by inducing cell competition. Cell (2004) 3.98
dMyc transforms cells into super-competitors. Cell (2004) 3.66
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli. Genetics (1994) 3.19
Chemical warfare between microbes promotes biodiversity. Proc Natl Acad Sci U S A (2002) 3.15
Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol (1994) 2.97
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology (2002) 2.88
Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem (2002) 2.58
Involvement of Lgl and Mahjong/VprBP in cell competition. PLoS Biol (2010) 2.45
The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.34
Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim (2006) 2.32
Characterization of the interface between normal and transformed epithelial cells. Nat Cell Biol (2009) 2.21
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res (2001) 2.06
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Clin Cancer Res (2006) 1.75
Is cell competition relevant to cancer? Nat Rev Cancer (2008) 1.71
Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Src-transformed cells. J Cell Sci (2009) 1.55
Meta analysis: Cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.50
Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst (1999) 1.44
Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis (2003) 1.39
Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol (2008) 1.38
Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol (2009) 1.37
Soluble factors mediate competitive and cooperative interactions between cells expressing different levels of Drosophila Myc. Proc Natl Acad Sci U S A (2007) 1.37
Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev (2001) 1.31
A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res (2001) 1.29
Steep differences in wingless signaling trigger Myc-independent competitive cell interactions. Dev Cell (2011) 1.29
Cell competition and its possible relation to cancer. Cancer Res (2008) 1.27
Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology (1998) 1.24
Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. Cancer Epidemiol Biomarkers Prev (2004) 1.22
Neosquamous epithelium does not typically arise from Barrett's epithelium. Clin Cancer Res (2006) 1.14
Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor. Cancer Res (1980) 1.14
Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab Invest (2004) 1.12
Many colorectal cancers are "flat" clonal expansions. Cell Cycle (2009) 1.10
Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2008) 1.08
Cell competition. Curr Biol (2011) 1.07
Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol (2007) 1.03
Interactions between normal and transformed epithelial cells: Their contributions to tumourigenesis. Int J Biochem Cell Biol (2010) 1.00
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab Invest (2008) 0.96
Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model. J Thorac Cardiovasc Surg (2007) 0.96
Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int J Cancer (1985) 0.94
Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. J Surg Res (2006) 0.94
Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen-embedded fibroblasts in organotypic culture. FASEB J (2003) 0.94
Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's esophagus. Dig Dis Sci (2004) 0.93
Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors. Cancer Res (1991) 0.92
Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer (2008) 0.89
Proton pump inhibitors reduce the bioavailability of dietary vitamin C. Aliment Pharmacol Ther (2005) 0.86
A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus. J Clin Pathol (2005) 0.85
The effect of cell-matrix interactions and aging on the malignant process. Adv Cancer Res (2007) 0.85
Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors. Cancer Res (1989) 0.81
Clonal evolution in cancer. Nature (2012) 11.07
Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2007) 3.00
Peto's Paradox: evolution's prescription for cancer prevention. Trends Ecol Evol (2011) 2.48
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res (2006) 2.24
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med (2007) 2.23
A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Phila) (2010) 1.89
Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays (2014) 1.64
Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila) (2008) 1.43
Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS One (2011) 1.32
Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) (2013) 1.31
Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res (Phila) (2011) 1.21
Animal cell differentiation patterns suppress somatic evolution. PLoS Comput Biol (2007) 1.19
Cancer in light of experimental evolution. Curr Biol (2012) 1.17
Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res (2009) 1.17
Life history trade-offs in cancer evolution. Nat Rev Cancer (2013) 1.16
Solving the puzzle of metastasis: the evolution of cell migration in neoplasms. PLoS One (2011) 1.12
The role of genetic diversity in cancer. J Clin Invest (2010) 1.05
Modelling the evolution of genetic instability during tumour progression. Evol Appl (2012) 1.04
Spatial structure increases the waiting time for cancer. New J Phys (2011) 1.02
Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Cancer Epidemiol Biomarkers Prev (2006) 0.98
NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet (2013) 0.98
Preneoplastic lesion growth driven by the death of adjacent normal stem cells. Proc Natl Acad Sci U S A (2008) 0.97
New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management. Clin Cancer Res (2011) 0.96
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biol Blood Marrow Transplant (2010) 0.95
Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prev Res (Phila) (2011) 0.91
Deletion at fragile sites is a common and early event in Barrett's esophagus. Mol Cancer Res (2010) 0.89
Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev (2006) 0.87
Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox. BMC Cancer (2012) 0.87
Sequence space coverage, entropy of genomes and the potential to detect non-human DNA in human samples. BMC Genomics (2008) 0.87
Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms. Arch Pathol Lab Med (2010) 0.84
An evolutionary explanation for the presence of cancer nonstem cells in neoplasms. Evol Appl (2012) 0.82
New models of neoplastic progression in Barrett's oesophagus. Biochem Soc Trans (2010) 0.80
Development and characterization of an organotypic model of Barrett's esophagus. J Cell Physiol (2012) 0.80
Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol (2005) 0.78
Polyploidy, aneuploidy and the evolution of cancer. Adv Exp Med Biol (2010) 0.78